LNWTC
INAB icon

Laird Norton Wetherby Trust Company’s IN8bio INAB Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,410
Closed -$35.8K – 89
2024
Q2 		$35.8K Hold
1,410
– – 0.01% 71
2024
Q1 		$49.9K Hold
1,410
– – 0.01% 76
2023
Q4 		$58.4K Buy
+1,410
New +$45.1K 0.01% 84

Other funds holding INAB

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return

Laird Norton Wetherby Trust Company's INAB Position: Q3 2024 in Review

Laird Norton Wetherby Trust Company sold out of IN8bio (INAB) in Q3 2024, closing a stake of 1,410 shares — an estimated $35.8K sold.

Laird Norton Wetherby Trust Company first reported a position in INAB in Q4 2023 and held it in 3 quarters. The position peaked at $58.4K in Q4 2023. 26 funds tracked by Wall St. Rank hold INAB as of Q3 2024.

  • Laird Norton Wetherby Trust Company reported no remaining IN8bio position as of Q3 2024 after selling out during the quarter.
  • Laird Norton Wetherby Trust Company sold 1,410 IN8bio shares in Q3 2024, an estimated $35.8K.
  • Laird Norton Wetherby Trust Company first reported a position in IN8bio in Q4 2023 and held it in 3 quarters.
  • Laird Norton Wetherby Trust Company's IN8bio position peaked at $58.4K in Q4 2023.
  • 26 funds tracked by Wall St. Rank held IN8bio as of Q3 2024.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q3 2024, filed 14 Nov 2024.